<DOC>
	<DOCNO>NCT00768040</DOCNO>
	<brief_summary>To assess efficacy oral aliskiren therapy diabetic macular edema</brief_summary>
	<brief_title>Efficacy Aliskiren Treatment Diabetic Macular Edema</brief_title>
	<detailed_description />
	<mesh_term>Macular Edema</mesh_term>
	<mesh_term>Edema</mesh_term>
	<criteria>Inclusion criterion : Type 1 type 2 diabetes Diabetic macular edema Exclusion criterion : Recent intraocular surgery study eye ( e.g. , cataract surgery last 6 month ) Recent laser photocoagulation study eye Recent treatment Avastin , Lucentis , intravitreal corticosteroid study eye Other protocoldefined inclusion/exclusion criterion apply</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>February 2012</verification_date>
	<keyword>Diabetes</keyword>
	<keyword>Macular edema</keyword>
	<keyword>Aliskiren</keyword>
	<keyword>Diabetic retinopathy</keyword>
	<keyword>Diabetes mellitus type 1</keyword>
	<keyword>Diabetes mellitus type 2</keyword>
</DOC>